4
Changes in Ownership
ALNYLAM PHARMACEUTICALS, INC. Filed Acc 0001735276-20-000109
Director sold 15,000 shares at $140.00 ($2,100,000)
- Director acquired 15,000 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
PAUL STEVEN M · Director
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 1 in the form | +15,000 | $9.30 | $139,500 | 16,000 | D |
| 2020-12-18 | Sale : show line 2 in the form | −15,000 | $140.00 | $2,100,000 | 1,000 | D |
| Open-market sales · 15,000 sh · avg $140.00 · $2,100,000 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| 2020-12-18 | Exercise or conversion : show line 3 in the form Stock Option (right to buy) | −15,000 | $9.30 | 2021-06-09 | 15,000 | 0 | D |
Loading xslF345X03/edgardoc.xml…